{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:43:18Z","timestamp":1781664198208,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0206-6","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T14:35:24Z","timestamp":1513953324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study"],"prefix":"10.1186","volume":"14","author":[{"given":"Julia","family":"Goldman-Hasbun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Nosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-7153","authenticated-orcid":false,"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths\u2014United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"206_CR2","volume-title":"Illicit drug overdose deaths in BC","author":"British Columbia Coroners Service","year":"2017","unstructured":"British Columbia Coroners Service: Illicit drug overdose deaths in BC. 2017. \n                    http:\/\/www2.gov.bc.ca\/assets\/gov\/public-safety-and-emergency-services\/death-investigation\/statistical\/illicit-drug.pdf\n                    \n                  . Accessed 8 Dec 2017."},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.addbeh.2017.03.024","volume":"72","author":"V Osborne","year":"2017","unstructured":"Osborne V, Serdarevic M, Crooke H, Striley C, Cottler LB. Non-medical opioid use in youth: gender differences in risk factors and prevalence. Addict Behav. 2017;72:114\u20139.","journal-title":"Addict Behav"},{"key":"206_CR4","unstructured":"Toward the Heart: Take home naloxone. \n                    http:\/\/towardtheheart.com\/naloxone\n                    \n                  . Accessed 15 Aug 2017."},{"key":"206_CR5","doi-asserted-by":"publisher","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013; \n                    https:\/\/doi.org\/10.1136\/bmj.f174\n                    \n                  .","DOI":"10.1136\/bmj.f174"},{"key":"206_CR6","volume-title":"The availability of take home naloxone in Canada","author":"Canadian Centre on Substance Abuse","year":"2016","unstructured":"Canadian Centre on Substance Abuse: The availability of take home naloxone in Canada. 2016. \n                    http:\/\/www.ccsa.ca\/Resource%20Library\/CCSA-CCENDU-Take-Home-Naloxone-Canada-2016-en.pdf\n                    \n                  . Accessed 15 Aug 2017."},{"key":"206_CR7","volume-title":"Opioid overdose: preventing and reducing opioid overdose mortality","author":"United Nations Office on Drug and Crime, World Health Organization","year":"2013","unstructured":"United Nations Office on Drug and Crime, World Health Organization: Opioid overdose: preventing and reducing opioid overdose mortality. 2013. \n                    http:\/\/www.who.int\/substance_abuse\/publications\/opioid_overdose.pdf?ua=1\n                    \n                  . Accessed 15 Aug 2017."},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111:1177\u201387.","journal-title":"Addiction"},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/14740338.6.2.125","volume":"6","author":"ELA van Dorp","year":"2007","unstructured":"van Dorp ELA, Yassen A, Dahan A. Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf. 2007;6:125\u201332.","journal-title":"Expert Opin Drug Saf"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.drugalcdep.2016.02.031","volume":"162","author":"A McAuley","year":"2016","unstructured":"McAuley A, Munro A, Bird SM, Hutchinson SJ, Goldberg DJ, Taylor A. Engagement in a National Naloxone Programme among people who inject drugs. Drug Alcohol Depend. 2016;162:236\u201340.","journal-title":"Drug Alcohol Depend"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugpo.2009.11.006","volume":"21","author":"S Merkinaite","year":"2010","unstructured":"Merkinaite S, Grund JP, Frimpong A. Young people and drugs: next generation of harm reduction. Int J Drug Policy. 2010;21:112\u20134.","journal-title":"Int J Drug Policy"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"19442","DOI":"10.7448\/IAS.18.2.19442","volume":"18","author":"A Krug","year":"2015","unstructured":"Krug A, Hildebrand M, Sun N. \u201cWe don\u2019t need services. We have no problems\u201d: exploring the experiences of young people who inject drugs in accessing harm reduction services. J Int AIDS Soc. 2015;18:19442.","journal-title":"J Int AIDS Soc"},{"key":"206_CR13","doi-asserted-by":"publisher","unstructured":"Panther SG, Bray BS, White JR. The implementation of a naloxone rescue program in university students. J Am Pharm Assoc. 2017; \n                    https:\/\/doi.org\/10.1016\/j.japh.2016.11.002.","DOI":"10.1016\/j.japh.2016.11.002."},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.17269\/cjph.107.5480","volume":"107","author":"P Leece","year":"2016","unstructured":"Leece P, Gassanov M, Hopkins S, Marshall C, Millson P, Shahin R. Process evaluation of the Prevent Overdose in Toronto (POINT) program. Can J Public Health. 2016;107:e224\u201330.","journal-title":"Can J Public Health."},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","volume":"69","author":"A Kestler","year":"2017","unstructured":"Kestler A, Buxton J, Meckling G, Giesler A, Lee M, Fuller K, Quian H, Marks D, Scheuermeyer F. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69:340\u20136.","journal-title":"Ann Emerg Med"},{"key":"206_CR16","doi-asserted-by":"publisher","unstructured":"Mitchell K, Durante SE, Pellatt K, Richardson CG, Mathias S, Buxton JA: Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people\u2019s perceptions of the BC take home naloxone program. 2017. Harm Reduct J. 2017. doi:\n                    https:\/\/doi.org\/10.1186\/s12954-017-0160-3\n                    \n                  .","DOI":"10.1186\/s12954-017-0160-3"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","volume":"94","author":"J Strang","year":"1999","unstructured":"Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, Welch S, Gossop M. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction. 1999;94:199\u2013204.","journal-title":"Addiction"},{"key":"206_CR18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF03405183","volume":"96","author":"JF Boivin","year":"2005","unstructured":"Boivin JF, Roy E, Haley N, Galbaud du Fort G. The health of street youth: a Canadian perspective. Can J Public Health. 2005;96:432\u20137.","journal-title":"Can J Public Health"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1054-139X(99)00059-2","volume":"25","author":"D DeMatteo","year":"1999","unstructured":"DeMatteo D, Major C, Block B, Coates R, Fearon M, Goldberg E, King SM, Millson M, O'Shaughnessy M, Read SE. Toronto street youth and HIV\/AIDS: prevalence, demographics, and risks. J Adolesc Health. 1999;25:358\u201366.","journal-title":"J Adolesc Health"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1471-2458-9-171","volume":"9","author":"T Kerr","year":"2009","unstructured":"Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, Wood E. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9:171.","journal-title":"BMC Public Health"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7517-3-18","volume":"3","author":"E Wood","year":"2006","unstructured":"Wood E, Stoltz JA, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3:18.","journal-title":"Harm Reduct J."},{"key":"206_CR22","doi-asserted-by":"publisher","unstructured":"Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Milloy MJ, Kerr T, Montaner J, Wood E. Awareness, possession, and use of take-home naloxone among illicit drug users, Vancouver, British Columbia, 2014-2015. Public Health Rep. 2017; \n                    https:\/\/doi.org\/10.1177\/0033354917717230\n                    \n                  .","DOI":"10.1177\/0033354917717230"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1360-0443.1998.9357016.x","volume":"93","author":"C McGregor","year":"1998","unstructured":"McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction. 1998;93:701\u201311.","journal-title":"Addiction"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7517-3-19","volume":"3","author":"N Worthington","year":"2006","unstructured":"Worthington N, Markham Piper T, Galea S, Rosenthal D. Opiate users\u2019 knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J. 2006;3:19.","journal-title":"Harm Reduct J"},{"key":"206_CR25","unstructured":"Toward the Heart: Naloxone wakes you up. \n                    http:\/\/towardtheheart.com\/ezine\/\n                    \n                  . Accessed 5 Sept 2017."},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.puhe.2007.02.016","volume":"122","author":"N Fairbairn","year":"2008","unstructured":"Fairbairn N, Wood E, Stoltz J-A, Li K, Montaner J, Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health. 2008;122:70\u20138.","journal-title":"Public Health"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","volume":"87","author":"T Kerr","year":"2007","unstructured":"Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87:39\u201345.","journal-title":"Drug Alcohol Depend"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jadohealth.2007.09.021","volume":"42","author":"D Werb","year":"2008","unstructured":"Werb D, Kerr T, Lai C, Montaner J, Wood E. Nonfatal overdose among a cohort of street-involved youth. J Adolesc Health. 2008;42:303\u20136.","journal-title":"J Adolesc Health"},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0306-4603(00)00115-5","volume":"26","author":"KC Ochoa","year":"2001","unstructured":"Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26:453\u201360.","journal-title":"Addict Behav"},{"key":"206_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40621-017-0118-7","volume":"4","author":"JE Brady","year":"2017","unstructured":"Brady JE, Giglio R, Keyes KM, DiMaggio C, Li G. Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis. Inj Epidemiol. 2017;4:24.","journal-title":"Inj Epidemiol"},{"key":"206_CR31","doi-asserted-by":"publisher","unstructured":"Chandra A, Minkovitz CS. Stigma starts early: gender differences in teen willingness to use mental health services. J Adolesc Health. 2006; \n                    https:\/\/doi.org\/10.1016\/j.jadohealth.2005.08.011\n                    \n                  .","DOI":"10.1016\/j.jadohealth.2005.08.011"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1054-139X(01)00319-6","volume":"30","author":"AV Marcell","year":"2002","unstructured":"Marcell AV, Klein JD, Fischer I, Allan MJ, Kokotailo PK. Male adolescent use of health care services: where are the boys? J Adolesc Health. 2002;30:35\u201343.","journal-title":"J Adolesc Health"},{"key":"206_CR33","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/j.1360-0443.2010.03077.x","volume":"105","author":"MJ Milloy","year":"2010","unstructured":"Milloy MJ, Wood E, Reading C, Kane D, Montaner J, Kerr T. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Addiction. 2010;105:1962\u201370.","journal-title":"Addiction"},{"key":"206_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.drugalcdep.2008.12.007","volume":"101","author":"JL Evans","year":"2009","unstructured":"Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO study). Drug Alcohol Depend. 2009;101:152\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"206_CR35","first-page":"293","volume":"165","author":"JJ Ochnio","year":"2001","unstructured":"Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ. 2001;165:293\u20137.","journal-title":"CMAJ"},{"key":"206_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jurban\/jti121","volume":"82","author":"C Steensma","year":"2005","unstructured":"Steensma C, Boivin JF, Blais L, Roy E. Cessation of injecting drug use among street-based youth. J Urban Health. 2005;82:622\u201337.","journal-title":"J Urban Health"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-017-0206-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:05:45Z","timestamp":1589540745000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0206-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The At-Risk Youth Study has been approved by the Providence Health Care\/University of British Columbia\u2019s Ethics Board. All participants provided informed consent prior to participating in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"79"}}